1. Home
  2. FFIV vs WST Comparison

FFIV vs WST Comparison

Compare FFIV & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIV
  • WST
  • Stock Information
  • Founded
  • FFIV 1996
  • WST 1923
  • Country
  • FFIV United States
  • WST United States
  • Employees
  • FFIV N/A
  • WST N/A
  • Industry
  • FFIV Computer Communications Equipment
  • WST Medical/Dental Instruments
  • Sector
  • FFIV Telecommunications
  • WST Health Care
  • Exchange
  • FFIV Nasdaq
  • WST Nasdaq
  • Market Cap
  • FFIV 18.0B
  • WST 18.9B
  • IPO Year
  • FFIV 1999
  • WST N/A
  • Fundamental
  • Price
  • FFIV $323.81
  • WST $256.66
  • Analyst Decision
  • FFIV Hold
  • WST Strong Buy
  • Analyst Count
  • FFIV 11
  • WST 8
  • Target Price
  • FFIV $314.90
  • WST $329.43
  • AVG Volume (30 Days)
  • FFIV 392.7K
  • WST 539.7K
  • Earning Date
  • FFIV 10-27-2025
  • WST 10-23-2025
  • Dividend Yield
  • FFIV N/A
  • WST 0.34%
  • EPS Growth
  • FFIV 22.06
  • WST N/A
  • EPS
  • FFIV 11.34
  • WST 6.68
  • Revenue
  • FFIV $3,024,656,000.00
  • WST $2,960,200,000.00
  • Revenue This Year
  • FFIV $11.86
  • WST $6.28
  • Revenue Next Year
  • FFIV $4.03
  • WST $6.02
  • P/E Ratio
  • FFIV $28.54
  • WST $38.47
  • Revenue Growth
  • FFIV 8.94
  • WST 2.90
  • 52 Week Low
  • FFIV $211.89
  • WST $187.43
  • 52 Week High
  • FFIV $337.39
  • WST $352.33
  • Technical
  • Relative Strength Index (RSI)
  • FFIV 55.98
  • WST 58.07
  • Support Level
  • FFIV $319.72
  • WST $254.35
  • Resistance Level
  • FFIV $337.39
  • WST $264.06
  • Average True Range (ATR)
  • FFIV 6.70
  • WST 5.88
  • MACD
  • FFIV 0.28
  • WST 0.41
  • Stochastic Oscillator
  • FFIV 59.80
  • WST 66.99

About FFIV F5 Inc.

F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Share on Social Networks: